MFG
SRNE

Merit Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Merit Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,780
Closed -$22K – 723
2022
Q3 		$22K Hold
13,780
– – ﹤0.01% 556
2022
Q2 		$28K Sell
13,780
-3,900
-22% -$6.74K ﹤0.01% 555
2022
Q1 		$41K Hold
17,680
– – ﹤0.01% 376
2021
Q4 		$82K Sell
17,680
-4,000
-18% -$24.8K 0.01% 272
2021
Q3 		$165K Hold
21,680
– – 0.02% 258
2021
Q2 		$210K Buy
21,680
+1,000
+5% +$7.96K 0.02% 253
2021
Q1 		$171K Buy
20,680
+1,000
+5% +$10.6K 0.02% 227
2020
Q4 		$134K Hold
19,680
– – 0.01% 207
2020
Q3 		$219K Buy
19,680
+5,680
+41% +$52K 0.02% 200
2020
Q2 		$88K Buy
+14,000
New +$53.6K 0.01% 210

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM